Suppr超能文献

中国南方地区连续十年肝硬化研究。

Study of liver cirrhosis over ten consecutive years in Southern China.

作者信息

Wang Xing, Lin Shang-Xiong, Tao Jin, Wei Xiu-Qing, Liu Yuan-Ting, Chen Yu-Ming, Wu Bin

机构信息

Xing Wang, Shang-Xiong Lin, Jin Tao, Xiu-Qing Wei, Bin Wu, Department of Gastroenterology, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, Guangdong Province, China.

出版信息

World J Gastroenterol. 2014 Oct 7;20(37):13546-55. doi: 10.3748/wjg.v20.i37.13546.

Abstract

AIM

To investigate the etiology and complications of liver cirrhosis (LC) in Southern China.

METHODS

In this retrospective, cross-sectional study, we identified cases of liver cirrhosis admitted between January 2001 to December 2010 and reviewed the medical records. Patient demographics, etiologies and complications were collected, and etiological changes were illustrated by consecutive years and within two time periods (2001-2005 and 2006-2010). All results were expressed as the mean ± SD or as a percentage. The χ(2) test or Student's t-test was used to analyze the differences in age, gender, and etiological distribution, and one-way analysis of variance was applied to estimate the trends in etiological changes. We analyzed the relationship between the etiologies and complications using unconditioned logistic regression, and the risk of upper gastrointestinal bleeding (UGIB) and hepatocellular carcinoma (HCC) in the major etiological groups was evaluated as ORs. A P value less than 0.05 was considered significant. Statistical computation was performed using SPSS 17.0 software.

RESULTS

In this study, we identified 6719 (83.16%) male patients and 1361 (16.84%) female patients. The average age of all of the patients was 50.5 years at the time of diagnosis. The distribution of etiological agents was as follows: viral hepatitis, 80.62% [hepatitis B virus (HBV) 77.22%, hepatitis C virus (HCV) 2.80%, (HBV + HCV) 0.58%]; alcohol, 5.68%; mixed etiology, 4.95%; cryptogenic, 2.93%; and autoimmune hepatitis, 2.03%; whereas the other included etiologies accounted for less than 4% of the total. Infantile hepatitis syndrome LC patients were the youngest (2.5 years of age), followed by the metabolic LC group (27.2 years of age). Viral hepatitis, alcohol, and mixed etiology were more prevalent in the male group, whereas autoimmune diseases, cryptogenic cirrhosis, and metabolic diseases were more prevalent in the female group. When comparing the etiological distribution in 2001-2005 with that in 2006-2010, the proportion of viral hepatitis decreased from 84.7% to 78.3% (P < 0.001), and the proportion of HBV-induced LC also decreased from 81.9% to 74.6% (P < 0.001). The incidence of mixed etiology, cryptogenic cirrhosis, and autoimmune diseases increased by 3.1% (P < 0.001), 0.5% (P = 0.158), and 1.3% (P < 0.001), respectively. Alcohol-induced LC remained relatively steady over the 10-year period. The ORs of the development of UGIB between HBV and other major etiologies were as follows: HCV, 1.07; alcohol, 1.89; autoimmune, 0.90; mixed etiology, 0.83; and cryptogenic, 1.76. The ORs of the occurrence of HCC between HBV and other major etiologies were as follows: HCV, 0.54; alcohol, 0.16; autoimmune, 0.05; mixed etiology, 0.58; and cryptogenic, 0.60.

CONCLUSION

The major etiology of liver cirrhosis in Southern China is viral hepatitis. However, the proportions of viral hepatitis and HBV are gradually decreasing. Alcoholic LC patients exhibit a greater risk of experiencing UGIB, and HBV LC patients may have a greater risk of HCC.

摘要

目的

探讨中国南方肝硬化(LC)的病因及并发症。

方法

在这项回顾性横断面研究中,我们确定了2001年1月至2010年12月期间收治的肝硬化病例,并查阅了病历。收集患者的人口统计学资料、病因及并发症,按连续年份及两个时间段(2001 - 2005年和2006 - 2010年)阐述病因变化。所有结果以均数±标准差或百分比表示。采用χ²检验或Student's t检验分析年龄、性别及病因分布的差异,应用单因素方差分析评估病因变化趋势。我们使用非条件逻辑回归分析病因与并发症之间的关系,并将主要病因组中上消化道出血(UGIB)和肝细胞癌(HCC)的风险评估为比值比(OR)。P值小于0.05被认为具有统计学意义。使用SPSS 17.0软件进行统计计算。

结果

本研究中,我们确定了6719例(83.16%)男性患者和1361例(16.84%)女性患者。所有患者诊断时的平均年龄为50.5岁。病因分布如下:病毒性肝炎,80.62%[乙型肝炎病毒(HBV)77.22%,丙型肝炎病毒(HCV)2.80%,(HBV + HCV)0.58%];酒精,5.68%;混合病因,4.95%;隐源性,2.93%;自身免疫性肝炎,2.03%;而其他病因占总数的比例不到4%。婴儿肝炎综合征LC患者最年轻(2.5岁),其次是代谢性LC组(27.2岁)。病毒性肝炎、酒精和混合病因在男性组中更常见,而自身免疫性疾病、隐源性肝硬化和代谢性疾病在女性组中更常见。比较2001 - 2005年与

相似文献

1
Study of liver cirrhosis over ten consecutive years in Southern China.
World J Gastroenterol. 2014 Oct 7;20(37):13546-55. doi: 10.3748/wjg.v20.i37.13546.
3
Study of liver cirrhosis over twenty consecutive years in adults in Southern China.
World J Hepatol. 2023 Dec 27;15(12):1294-1306. doi: 10.4254/wjh.v15.i12.1294.
5
The transition in the etiologies of hepatocellular carcinoma-complicated liver cirrhosis in a nationwide survey of Japan.
J Gastroenterol. 2021 Feb;56(2):158-167. doi: 10.1007/s00535-020-01748-x. Epub 2020 Nov 20.
6
The role of diabetes in hepatocellular carcinoma: a case-control study among United States Veterans.
Am J Gastroenterol. 2001 Aug;96(8):2462-7. doi: 10.1111/j.1572-0241.2001.04054.x.
9
Etiology of liver cirrhosis in Japan: a nationwide survey.
J Gastroenterol. 2010;45(1):86-94. doi: 10.1007/s00535-009-0128-5. Epub 2009 Sep 30.

引用本文的文献

1
Etiology and Prognostic Criteria for Liver Failure in Southeast China: A Multicenter Retrospective Cohort Study Between 2018 and 2020.
Gastroenterol Res Pract. 2024 Dec 18;2024:5512889. doi: 10.1155/grp/5512889. eCollection 2024.
2
ICG-r15 predicts esophageal varices in compensated liver cirrhosis: a noninvasive approach.
BMC Gastroenterol. 2024 Nov 1;24(1):390. doi: 10.1186/s12876-024-03407-4.
4
Comparison of Clinical Manifestations and Related Factors of Hepatocellular Carcinoma with Chronic Hepatitis B.
Int J Gen Med. 2024 Jun 25;17:2877-2886. doi: 10.2147/IJGM.S464083. eCollection 2024.
6
Trends in Mortality of Cirrhosis in China: An Analysis of the China Death Surveillance Database from 2008 to 2020.
J Clin Transl Hepatol. 2024 Mar 28;12(3):236-244. doi: 10.14218/JCTH.2023.00454. Epub 2024 Jan 22.
7
Study of liver cirrhosis over twenty consecutive years in adults in Southern China.
World J Hepatol. 2023 Dec 27;15(12):1294-1306. doi: 10.4254/wjh.v15.i12.1294.
8
The Burden of Inappropriate Prescriptions and Predictors for Hospitalized Patients with Liver Cirrhosis in Ethiopia.
Hepat Med. 2023 Sep 25;15:129-140. doi: 10.2147/HMER.S423351. eCollection 2023.
9
Trends of hospitalisation for patients with liver cirrhosis in Ningxia, China: a cross-sectional study.
BMJ Open. 2023 Aug 22;13(8):e068655. doi: 10.1136/bmjopen-2022-068655.

本文引用的文献

1
Etiological features of cirrhosis inpatients in Beijing, China.
Chin Med J (Engl). 2013 Jul;126(13):2430-4.
2
The burden of liver disease in Europe: a review of available epidemiological data.
J Hepatol. 2013 Mar;58(3):593-608. doi: 10.1016/j.jhep.2012.12.005.
3
Survey of non-B, non-C liver cirrhosis in Japan.
Hepatol Res. 2013 Oct;43(10):1020-31. doi: 10.1111/hepr.12056. Epub 2013 Jan 25.
5
Impact of hepatitis B vaccination among children in Guangdong Province, China.
Int J Infect Dis. 2012 Sep;16(9):e692-6. doi: 10.1016/j.ijid.2012.05.1027. Epub 2012 Jul 13.
6
Hepatocellular carcinoma.
Lancet. 2012 Mar 31;379(9822):1245-55. doi: 10.1016/S0140-6736(11)61347-0. Epub 2012 Feb 20.
8
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008.
Int J Cancer. 2010 Dec 15;127(12):2893-917. doi: 10.1002/ijc.25516.
10
Portopulmonary hypertension and right heart failure in patients with cirrhosis.
Curr Opin Anaesthesiol. 2010 Apr;23(2):145-50. doi: 10.1097/ACO.0b013e32833725c4.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验